Guidelines of care for the management of cutaneous squamous cell carcinoma

Work Group, Invited Reviewers

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. Topics addressed include biopsy techniques and histopathologic assessment, tumor staging, surgical and nonsurgical management, follow-up and prevention of recurrence, and management of advanced disease. The primary focus of these recommendations is on evaluation and management of primary cSCC and localized disease, but where relevant, applicability to recurrent cSCC is noted, as is general information on the management of patients with metastatic disease.

Original languageEnglish (US)
Pages (from-to)560-578
Number of pages19
JournalJournal of the American Academy of Dermatology
Volume78
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Squamous Cell Carcinoma
Guidelines
Skin
Information Management
Neoplasm Staging
Disease Management
Quality of Life
Morbidity
Biopsy
Recurrence
Incidence
Neoplasms
Therapeutics

Keywords

  • biopsy
  • curettage
  • metastasis
  • phototherapy
  • radiotherapy
  • squamous cell carcinoma
  • staging
  • surgery
  • surveillance
  • topical therapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Guidelines of care for the management of cutaneous squamous cell carcinoma. / Work Group; Invited Reviewers.

In: Journal of the American Academy of Dermatology, Vol. 78, No. 3, 01.03.2018, p. 560-578.

Research output: Contribution to journalArticle

@article{083d178c2cb34abda4e72dec21f5c662,
title = "Guidelines of care for the management of cutaneous squamous cell carcinoma",
abstract = "Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. Topics addressed include biopsy techniques and histopathologic assessment, tumor staging, surgical and nonsurgical management, follow-up and prevention of recurrence, and management of advanced disease. The primary focus of these recommendations is on evaluation and management of primary cSCC and localized disease, but where relevant, applicability to recurrent cSCC is noted, as is general information on the management of patients with metastatic disease.",
keywords = "biopsy, curettage, metastasis, phototherapy, radiotherapy, squamous cell carcinoma, staging, surgery, surveillance, topical therapy",
author = "{Work Group} and {Invited Reviewers} and Murad Alam and April Armstrong and Christian Baum and Bordeaux, {Jeremy S.} and Marc Brown and Busam, {Klaus J.} and Eisen, {Daniel B} and Vivek Iyengar and Clifford Lober and Margolis, {David J.} and Jane Messina and Alexander Miller and Stanley Miller and Eliot Mostow and Christen Mowad and Kishwer Nehal and Kristi Schmitt-Burr and Aleksandar Sekulic and Paul Storrs and Joyce Teng and Siegrid Yu and Conway Huang and Kevin Boyer and Begolka, {Wendy Smith} and Christopher Bichakjian and Kim, {John Y.S.} and Kozlow, {Jeffrey H.} and Bharat Mittal and Jeffrey Moyer and Thomas Olenecki and Phillip Rodgers",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.jaad.2017.10.007",
language = "English (US)",
volume = "78",
pages = "560--578",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Guidelines of care for the management of cutaneous squamous cell carcinoma

AU - Work Group

AU - Invited Reviewers

AU - Alam, Murad

AU - Armstrong, April

AU - Baum, Christian

AU - Bordeaux, Jeremy S.

AU - Brown, Marc

AU - Busam, Klaus J.

AU - Eisen, Daniel B

AU - Iyengar, Vivek

AU - Lober, Clifford

AU - Margolis, David J.

AU - Messina, Jane

AU - Miller, Alexander

AU - Miller, Stanley

AU - Mostow, Eliot

AU - Mowad, Christen

AU - Nehal, Kishwer

AU - Schmitt-Burr, Kristi

AU - Sekulic, Aleksandar

AU - Storrs, Paul

AU - Teng, Joyce

AU - Yu, Siegrid

AU - Huang, Conway

AU - Boyer, Kevin

AU - Begolka, Wendy Smith

AU - Bichakjian, Christopher

AU - Kim, John Y.S.

AU - Kozlow, Jeffrey H.

AU - Mittal, Bharat

AU - Moyer, Jeffrey

AU - Olenecki, Thomas

AU - Rodgers, Phillip

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. Topics addressed include biopsy techniques and histopathologic assessment, tumor staging, surgical and nonsurgical management, follow-up and prevention of recurrence, and management of advanced disease. The primary focus of these recommendations is on evaluation and management of primary cSCC and localized disease, but where relevant, applicability to recurrent cSCC is noted, as is general information on the management of patients with metastatic disease.

AB - Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. Topics addressed include biopsy techniques and histopathologic assessment, tumor staging, surgical and nonsurgical management, follow-up and prevention of recurrence, and management of advanced disease. The primary focus of these recommendations is on evaluation and management of primary cSCC and localized disease, but where relevant, applicability to recurrent cSCC is noted, as is general information on the management of patients with metastatic disease.

KW - biopsy

KW - curettage

KW - metastasis

KW - phototherapy

KW - radiotherapy

KW - squamous cell carcinoma

KW - staging

KW - surgery

KW - surveillance

KW - topical therapy

UR - http://www.scopus.com/inward/record.url?scp=85050717330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050717330&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2017.10.007

DO - 10.1016/j.jaad.2017.10.007

M3 - Article

C2 - 29331386

AN - SCOPUS:85050717330

VL - 78

SP - 560

EP - 578

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -